Mounjaro, Zepbound May Lower Risk of Eye Disease in People With Diabetes

Weight loss medications Mounjaro and Zepbound, which contain the active ingredient tirzepatide, may lower the risk of diabetic retinopathy.
Healthline Daily News
Labcorp
February 21, 2026
Mounjaro, Zepbound May Lower Risk of Eye Disease in People With Diabetes
 
READ ON
→
Trump's Prescription Drug Plan to Lower Prices of GLP-1s, Other High Cost Meds
 
READ ON
→
Sugar-Sweetened Drinks May Trigger Anxiety in Young People, Study Finds
 
READ ON
→
Side Effects of Rezdiffra: What You Need to Know
 
READ ON
→
MORE STORIES
 
 
 
Sponsored
Check Your Heart Health with Labcorp OnDemand
Gain deeper insights into your cardiovascular health. Use code HEALTHLINE for 10% off a Comprehensive Heart Health Test.
SHOP NOW  →
  Check Your Heart Health with Labcorp OnDemand
 
 
 
PRODUCT PICK
 
TODAY'S RESOURCE
 
What we're reading next
Everything You Need to Know to Get Healthy, Long Eyelashes
Types of Sleep Apnea
The Mind-Heart Connection
Biking for Weight Loss: 4 Effective Strategies to Try
FOLLOW US ON INSTAGRAM
@healthline
healthline
fb   tiktok   X   youtube   insta

Post a Comment

Previous Post Next Post

Contact Form